» Articles » PMID: 32393902

Ubiquitin Chain-elongating Enzyme UBE2S Activates the RING E3 Ligase APC/C for Substrate Priming

Abstract

The interplay between E2 and E3 enzymes regulates the polyubiquitination of substrates in eukaryotes. Among the several RING-domain E3 ligases in humans, many utilize two distinct E2s for polyubiquitination. For example, the cell cycle regulatory E3, human anaphase-promoting complex/cyclosome (APC/C), relies on UBE2C to prime substrates with ubiquitin (Ub) and on UBE2S to extend polyubiquitin chains. However, the potential coordination between these steps in ubiquitin chain formation remains undefined. While numerous studies have unveiled how RING E3s stimulate individual E2s for Ub transfer, here we change perspective to describe a case where the chain-elongating E2 UBE2S feeds back and directly stimulates the E3 APC/C to promote substrate priming and subsequent multiubiquitination by UBE2C. Our work reveals an unexpected model for the mechanisms of RING E3-dependent ubiquitination and for the diverse and complex interrelationship between components of the ubiquitination cascade.

Citing Articles

APC/C-mediated ubiquitylation of extranucleosomal histone complexes lacking canonical degrons.

Skrajna A, Bodrug T, Martinez-Chacin R, Fisher C, Welsh K, Simmons H Nat Commun. 2025; 16(1):2561.

PMID: 40089476 DOI: 10.1038/s41467-025-57384-7.


Dynamics of spindle assembly and position checkpoints: Integrating molecular mechanisms with computational models.

Ibrahim B Comput Struct Biotechnol J. 2025; 27:321-332.

PMID: 39897055 PMC: 11782880. DOI: 10.1016/j.csbj.2024.12.021.


Ubiquitination Enzymes in Cancer, Cancer Immune Evasion, and Potential Therapeutic Opportunities.

Awan A, Osman M, Khan O Cells. 2025; 14(2).

PMID: 39851497 PMC: 11763706. DOI: 10.3390/cells14020069.


TRMT13 inhibits the growth of papillary thyroid cancer by targeting ANAPC4.

Liu L, Wang Y, Zou M, Chen S, Wu F, Li X Acta Biochim Biophys Sin (Shanghai). 2024; 56(9):1267-1277.

PMID: 38425244 PMC: 11532200. DOI: 10.3724/abbs.2024010.


Function, mechanism and drug discovery of ubiquitin and ubiquitin-like modification with multiomics profiling for cancer therapy.

Jiang Y, Ni S, Xiao B, Jia L Acta Pharm Sin B. 2023; 13(11):4341-4372.

PMID: 37969742 PMC: 10638515. DOI: 10.1016/j.apsb.2023.07.019.


References
1.
Metzger M, Pruneda J, Klevit R, Weissman A . RING-type E3 ligases: master manipulators of E2 ubiquitin-conjugating enzymes and ubiquitination. Biochim Biophys Acta. 2013; 1843(1):47-60. PMC: 4109693. DOI: 10.1016/j.bbamcr.2013.05.026. View

2.
Frederick C Streich Jr , Lima C . Structural and functional insights to ubiquitin-like protein conjugation. Annu Rev Biophys. 2014; 43:357-79. PMC: 4118471. DOI: 10.1146/annurev-biophys-051013-022958. View

3.
Rape M . Ubiquitylation at the crossroads of development and disease. Nat Rev Mol Cell Biol. 2017; 19(1):59-70. DOI: 10.1038/nrm.2017.83. View

4.
Buetow L, Huang D . Structural insights into the catalysis and regulation of E3 ubiquitin ligases. Nat Rev Mol Cell Biol. 2016; 17(10):626-42. PMC: 6211636. DOI: 10.1038/nrm.2016.91. View

5.
King R, Deshaies R, Peters J, Kirschner M . How proteolysis drives the cell cycle. Science. 1996; 274(5293):1652-9. DOI: 10.1126/science.274.5293.1652. View